Rakesh K. Jain
Molecular Biology · 2000–2020
A researcher in the Science corpus: 57 papers; trusts 86 researchers and is trusted by 241 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 481 citations into it; #63 of 17,836 by trust here, #135 by citations
- Oncology — 331 citations into it; #14 of 1,698 by trust here, #60 by citations
- Cancer Research — 210 citations into it; #3 of 1,784 by trust here, #32 by citations
- Immunology — 147 citations into it
- Cell Biology — 107 citations into it; #1,864 of 2,073 by trust here, #362 by citations
- Biomedical Engineering — 95 citations into it; #253 of 10,753 by trust here, #397 by citations
- Pulmonary and Respiratory Medicine — 86 citations into it
- Genetics — 57 citations into it; #2,701 of 6,875 by trust here, #961 by citations
Whom Rakesh K. Jain trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Peter Carmeliet
- N. Ferrara
- Ricky T. Tong
- Y. Boucher
- D. Hanahan
- F. Winkler
- Dai Fukumura
- Lance L. Munn
- Vikash P Chauhan
- Triantafyllos Stylianopoulos
Who trusts Rakesh K. Jain overall
- Dai Fukumura
- Peter Carmeliet
- N. Ferrara
- Triantafyllos Stylianopoulos
- Michael L. Lovett
- C. Viallard
- John D. Martin
- Vasilis Ntziachristos
- Ricky T. Tong
- Zhenling Liu
Papers from Rakesh K. Jain's perspective
Ordered by how strongly the researchers Rakesh K. Jain trusts endorse each paper. Same corpus, a different order for every researcher.
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Angiogenesis in life, disease and medicine (Nature)
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
- Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (Cancer Cell)
- Molecular mechanisms and clinical applications of angiogenesis (Nature)
Their papers
- Angiogenesis in cancer and other diseases (2000) — 9,280 citations
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (2001) — 2,258 citations
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (2005) — 5,585 citations
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) — 2,071 citations
- Molecular mechanisms and clinical applications of angiogenesis (2011) — 5,233 citations
- Molecular regulation of vessel maturation (2003) — 2,605 citations
- Dissecting tumour pathophysiology using intravital microscopy (2002) — 618 citations
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (2004) — 1,208 citations
- Pathology: Cancer cells compress intratumour vessels (2004) — 856 citations
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. (2004) — 1,344 citations
- Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics (2002) — 988 citations
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (2007) — 1,814 citations
- Transport of molecules across tumor vasculature (2004) — 675 citations
- Openings between defective endothelial cells explain tumor vessel leakiness. (2000) — 1,654 citations
- Lessons from phase III clinical trials on anti-VEGF therapy for cancer (2006) — 1,099 citations
- Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. (2000) — 706 citations
- Delivering nanomedicine to solid tumors (2010) — 2,997 citations
- Tumour biology: Herceptin acts as an anti-angiogenic cocktail (2002) — 687 citations
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (2011) — 694 citations
- NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES (2011) — 1,574 citations